TRIgyceride And Glucose Control With Epeleuton in Metabolic Syndrome Patients
Status:
Recruiting
Trial end date:
2022-09-15
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of orally administered Epeleuton capsules versus placebo,
in the treatment of adult patients with hypertriglyceridemia and type 2 diabetes